NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

This is such old recycled trash.

Anyway,

Companies work out terms of joint patents ahead of time. They are not enemies as you well know, and NWBO is obviously the orchestrator of unreleased terms.

You know which patent I’m talking about. Not the narrow one.

NWBO is likely the least concerned that the combination patent only covers gliomas.

NWBO intends to use DCVax-l for all solid tumors. It will likely very soon have biologic exclusivity for ten years from approval. Something I believe Keytruda loses in September of this year, and loses its patent in 2028.

The point is, that combo patent and combo trial go hand in hand in terms of rights.

For ici, LC and you to suggest NWBO is out of the picture because they did not run the trials but only prosecuted the joint patent (with obvious internal assignments and agreements) is just dimwitted.